Estimating Cost Savings From A CME Activity To Prevent Bleeding-Related Complications

May 19, 2015 8:00 AM – 9:30 AM

Dana Ravyn, PhD, MPH, Rob Lowney, MBA

Few studies report the economic impact of CME activities. Analysis of patient-level economic outcomes data is often not feasible. Accordingly, we developed a model to estimate the potential economic impact associated with CME activity outcomes. Outcomes impact analysis estimated the costs averted from a CME symposium that promoted prevention of bleeding-related complications (BRC) and reoperation for bleeding (RFB) in cardiac and thoracic operations. Model parameter estimates were from studies of costs associated with BRC and RFB. Operative volume estimates came from the Society of Thoracic Surgeons workforce data. The base case predicted 3 in 10 participants preventing one BRC or RFB in 2% or 1.5% of annual operations, respectively. A total of 93.8% of participants (n=133) reported commitment to change, a validated measure of behavior change. For BRC, estimates for costs averted were $1,502,769 (95% CI, $869,860–$2,359,068) for cardiac operations and $2,715,246 (95% CI, $1,590,308-$4,217,092) for thoracic operations. For RFB, the savings estimates were $2,233,988 (95% CI, $1,223,901–$3,648,719). Plausible economic models suggest that application of CME-related learning to prevent bleeding complications may yields substantial cost savings. Model prediction of averted costs associated with CME allows estimation of the economic impact on outcomes in the absence of patient-level outcomes data related to CME activities.